Huaxin Sheng Selected Research

Apolipoproteins E (ApoE)

7/2014	ApoE mimetic ameliorates motor deficit and tissue damage in rat spinal cord injury.
1/2006	A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huaxin Sheng Research Topics

Disease

21	Ischemia 10/2023 - 05/2002
17	Stroke (Strokes) 10/2023 - 10/2002
16	Brain Ischemia (Cerebral Ischemia) 01/2023 - 10/2002
10	Ischemic Stroke 10/2023 - 06/2015
10	Heart Arrest (Cardiac Arrest) 01/2023 - 01/2018
10	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 05/2002
8	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2023 - 09/2002
8	Neurologic Manifestations (Neurological Manifestations) 01/2023 - 10/2002
7	Infarction (Infarctions) 01/2019 - 10/2002
6	Brain Injuries (Brain Injury) 01/2023 - 12/2002
6	Cerebral Infarction 01/2022 - 05/2002
5	Cerebral Hemorrhage 01/2017 - 12/2012
5	Hemorrhage 01/2016 - 07/2002
4	Inflammation (Inflammations) 01/2023 - 07/2010
4	Hypoxia (Hypoxemia) 01/2023 - 02/2006
4	Hypotension (Low Blood Pressure) 01/2023 - 11/2003
4	Neoplasms (Cancer) 01/2021 - 04/2011
4	Neuroinflammatory Diseases 01/2021 - 01/2016
4	Spinal Cord Injuries (Spinal Cord Injury) 06/2015 - 05/2004
4	Transient Ischemic Attack 03/2014 - 02/2008
3	Wounds and Injuries (Trauma) 01/2021 - 04/2011
3	Brain Edema (Cerebral Edema) 01/2016 - 01/2006
3	Spinal Cord Compression 06/2015 - 05/2004
2	Asphyxia (Suffocation) 01/2023 - 01/2021
2	Central Nervous System Diseases (CNS Diseases) 01/2022 - 05/2014
2	Lymphopenia (Lymphocytopenia) 01/2021 - 01/2021
2	Atrophy 01/2021 - 01/2021
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 11/2015
2	Body Weight (Weight, Body) 01/2019 - 07/2014
2	Hematoma 01/2016 - 07/2014
2	Hypothermia 12/2012 - 05/2002
2	Thrombosis (Thrombus) 02/2011 - 02/2003
2	Closed Head Injuries 02/2006 - 01/2006
2	Intracranial Vasospasm 12/2002 - 09/2002
1	Brain Hypoxia (Cerebral Hypoxia) 01/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2023
1	Shock 01/2023
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2022
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 07/2022

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 07/2022 - 12/2002
8	PorphyrinsIBA 10/2023 - 02/2006
6	UbiquitinIBA 02/2016 - 05/2008
6	AntioxidantsIBA 04/2011 - 10/2002
4	ManganeseIBA 10/2023 - 08/2004
4	Oxygen (Dioxygen)IBA 01/2023 - 02/2012
4	Anesthetics (Anesthetic Agents)IBA 10/2016 - 11/2003
4	Isoflurane FDA LinkGeneric 01/2007 - 11/2003
3	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 02/2012
3	Epinephrine (Adrenaline)FDA LinkGeneric 01/2023 - 10/2018
3	CytokinesIBA 01/2021 - 01/2016
3	salicylhydroxamic acid (SHAM)IBA 01/2021 - 04/2014
3	Superoxides (Superoxide)IBA 05/2014 - 09/2002
3	Fentanyl (Sublimaze)FDA LinkGeneric 07/2006 - 11/2003
3	AEOL 10150IBA 08/2004 - 10/2002
2	NF-kappa B (NF-kB)IBA 01/2023 - 02/2008
2	RNA (Ribonucleic Acid)IBA 04/2022 - 01/2020
2	Neuroprotective AgentsIBA 01/2022 - 01/2016
2	thiamet GIBA 01/2021 - 01/2017
2	manganese (III) meso- tetrakis(N- ethylpyridinium- 2- yl)porphyrinIBA 01/2021 - 02/2006
2	Therapeutic UsesIBA 01/2021 - 01/2013
2	hydroxide ionIBA 01/2020 - 05/2013
2	Tamoxifen FDA LinkGeneric 01/2020 - 03/2017
2	NitrogenIBA 01/2019 - 09/2004
2	CreatinineIBA 01/2018 - 02/2013
2	Protein Isoforms (Isoforms)IBA 01/2018 - 01/2006
2	Progesterone FDA LinkGeneric 01/2016 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 02/2008
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 07/2010
2	Superoxide DismutaseIBA 11/2015 - 09/2002
2	Apolipoproteins E (ApoE)IBA 07/2014 - 01/2006
2	MetalloporphyrinsIBA 05/2014 - 10/2002
2	Peroxynitrous Acid (Peroxynitrite)IBA 05/2014 - 04/2011
2	ProteomeIBA 04/2014 - 03/2014
2	Hemoglobins (Hemoglobin)IBA 02/2011 - 05/2002
2	Dichlorodiphenyldichloroethane (DDD)IBA 10/2009 - 08/2004
2	Simvastatin (Zocor)FDA LinkGeneric 10/2009 - 12/2002
2	Nitrous Oxide (Laughing Gas)IBA 07/2006 - 05/2004
2	manganese(III) porphyrinIBA 02/2006 - 08/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2002 - 10/2002
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2023
1	Oxyhemoglobins (Oxyhemoglobin)IBA 01/2023
1	VenomsIBA 01/2023
1	Sirtuin 1IBA 01/2023
1	Immunoglobulin E (IgE)IBA 01/2023
1	AllergensIBA 01/2023
1	Chymases (Chymase)IBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2022
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 05/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 04/2022
1	Small Cytoplasmic RNAIBA 04/2022

Therapy/Procedure

8	Therapeutics 10/2023 - 08/2004
8	Resuscitation 01/2023 - 01/2018
4	Cardiopulmonary Resuscitation (CPR) 01/2023 - 01/2018
2	Vagus Nerve Stimulation 04/2022 - 01/2022
2	Transplantation 01/2017 - 04/2007
2	Anesthesia 10/2016 - 05/2004
2	Duration of Therapy 12/2012 - 10/2009
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 08/2011 - 07/2010
1	Thrombectomy 10/2023
1	Electric Stimulation Therapy (Electrotherapy) 01/2022